Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management

Because anti-tumor necrosis factor (anti-TNF) therapy has become increasingly popular in many Asian countries, the risk of developing active tuberculosis (TB) among anti-TNF users may raise serious health problems in this region. Thus, the Asian Organization for Crohn's and Colitis and the Asia...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Dong Il, Hisamatsu, Tadakazu, Chen, Minhu, Ng, Siew Chien, Ooi, Choon Jin, Wei, Shu Chen, Banerjee, Rupa, Hilmi, Ida Normiha, Jeen, Yoon Tae, Han, Dong Soo, Kim, Hyo Jong, Ran, Zhihua, Wu, Kaichun, Qian, Jiaming, Hu, Pin-Jin, Matsuoka, Katsuyoshi, Andoh, Akira, Suzuki, Yasuo, Sugano, Kentaro, Watanabe, Mamoru, Hibi, Toshifumi, Puri, Amarender S., Yang, Suk-Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2018
Materias:
Special Review: Consensus on TB in IBD
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797267/
https://www.ncbi.nlm.nih.gov/pubmed/29422794
http://dx.doi.org/10.5217/ir.2018.16.1.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797267/
https://www.ncbi.nlm.nih.gov/pubmed/29422794
http://dx.doi.org/10.5217/ir.2018.16.1.17

Ejemplares similares